YARROW BIOSCIENCE, INC. Increase (Decrease) in Receivables
YARROW BIOSCIENCE, INC. (YARW) reported Increase (Decrease) in Receivables of $77.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2023-11-13
- YARROW BIOSCIENCE, INC. increase (decrease) in receivables for the quarter ending 2023-09-30 was $16.00K, a 90.42% decline year-over-year.
- YARROW BIOSCIENCE, INC. increase (decrease) in receivables for the quarter ending 2023-06-30 was $129.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in receivables for the quarter ending 2023-03-31 was -$68.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in receivables for the quarter ending 2022-09-30 was $167.00K.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 3 month as first filed | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 6 month as first filed | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 9 month as first filed |
|---|---|---|---|---|---|---|
| 2023-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $145.00K derived: sum of 2 quarters · filed 2023-11-13 | $77.00K 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $61.00K 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | -$68.00K 10-Q · filed 2023-05-11 | |||||
| 2022-09-30 | $167.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$64.00K derived: sum of 2 quarters · filed 2023-11-13 | -$8.05M 10-Q · filed 2023-11-13 | -$8.85M 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | -$231.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$8.21M 10-Q · filed 2023-08-14 | -$7.98M 10-Q · filed 2022-08-12 | |||
| 2022-03-31 | -$7.98M 10-Q · filed 2023-05-11 | -$7.05M 10-Q · filed 2022-05-12 | ||||
| 2021-09-30 | -$996.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$198.00K derived: sum of 2 quarters · filed 2022-11-14 | -$5.26M 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $798.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$4.27M 10-Q · filed 2022-08-12 | ||||
| 2021-03-31 | -$5.06M 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |